132431-11-9 Usage
General Description
The chemical "1,2-Pyrrolidinedicarboxylic acid, 4-oxo-, 2-Methyl 1-(phenylMethyl) ester, (R)-" is a complex organic compound that is typically found in a solid state. It belongs to the esters class of chemical compounds, which are characterized by a carbon-oxygen double bond. Due to the presence of its phenyl group, it may have aromatic characteristics. The "(R)-" in its name indicates it has a specific orientation in space; in this case, it is a right-handed or rectus configuration. Its various chemical groups give it potential reactivity with various other substances, making it of interest in the field of organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 132431-11-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,2,4,3 and 1 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 132431-11:
(8*1)+(7*3)+(6*2)+(5*4)+(4*3)+(3*1)+(2*1)+(1*1)=79
79 % 10 = 9
So 132431-11-9 is a valid CAS Registry Number.
132431-11-9Relevant articles and documents
PYRROLIDINE GPR40 MODULATORS
-
Page/Page column 73, (2015/11/27)
The present invention provides compounds of Formula (I): or a stereoisomer, a tautomer, a pharmaceutically acceptable salt, a polymorph, or a solvate thereof, wherein all of the variables are as defined herein. These compounds are GPR40 G protein-coupled receptor modulators which may be used as medicaments.
PYRROLIDINE GPR40 MODULATORS
-
Paragraph 00469, (2014/06/11)
The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are GPR40 G protein-coupled receptor modulators which may be used as medicaments.
HEPATITIS C VIRUS INHIBITORS
-
, (2009/12/02)
Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.